Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Nature Genetics|December 12, 2018
Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor-directed therapiesUtthara Nayar, Ofir Cohen, Christian Kapstad, et al.
JCO Precision Oncology|May 4, 2023
Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker AnalysisLorenzo Gerratana, Andrew A Davis, Marko Velimirovic, et al.
Pharmacological Reviews|March 27, 2025
Cell cycle dysregulation in cancerAntonino Glaviano, Samarendra K Singh, E Hui Clarissa Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2025
TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast CancerRachel O Abelman, Bogang Wu, Haley Barnes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2020
Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast CancerPingping Mao, Ofir Cohen, Kailey J Kowalski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2024
Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast CancerAditya Bardia, Sheng Sun, Nayana Thimmiah, et al.
NPJ Breast Cancer|January 8, 2025
Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER)Laura M Spring, Lauren Scarpetti, Arielle J Medford, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|June 29, 2024
Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatmentAntonino Glaviano, Seth A Wander, Richard D Baird, et al.
Cancer Research|January 9, 2016
Interactions between Adipocytes and Breast Cancer Cells Stimulate Cytokine Production and Drive Src/Sox2/miR-302b-Mediated Malignant ProgressionManuel Picon-Ruiz, Chendong Pan, Katherine Drews-Elger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 18, 2024
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer After Progression on CDK4/6 Inhibition: Results From the Phase III postMONARCH TrialKevin Kalinsky, Giampaolo Bianchini, Erika Hamilton, et al.
Pageof 8